Login / Signup

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.

Heinz LudwigThomas MelchardtSiegfried SormannMartin SchrederJohannes AndelBernd HartmannChristoph TinchonNiklas ZojerEberhard GunsiliusKlaus PodarAlexander EgleWolfgang WillenbacherEwald WöllReinhard RuckserBoris BozicMaria-Theresa KrauthAndreas PetzerClemens SchmittSigrid Machherndl-SpandlHermine AgisMichael FillitzSong-Yau WangAugust ZaberniggStefan KnopBruno PaivaRichard Greil
Published in: American journal of hematology (2024)
Randomized comparison between KTd and KRd induction followed by second randomization to carfilzomib in transplant-ineligable patients with newly diagnosed multiple myeloma.
Keyphrases
  • multiple myeloma
  • newly diagnosed
  • double blind
  • open label
  • placebo controlled
  • phase iii
  • phase ii
  • randomized controlled trial
  • stem cells
  • cell therapy
  • bone marrow
  • replacement therapy